ASP Isotopes (ASPI) Capital Expenditures (2022 - 2026)

ASP Isotopes' Capital Expenditures history runs 5 years deep, the most recent figure standing at $6.1 million for Q1 2026.

• On a quarterly basis, Capital Expenditures rose 165.79% year-over-year to $6.1 million in Q1 2026; TTM through Mar 2026 was $13.5 million, a 13.07% increase from a year earlier, with the FY2025 full-year figure at $9.7 million, changed 0.22% from the prior year.
• Capital Expenditures grew to $6.1 million in Q1 2026 per ASPI's latest filing, from $2.4 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $9.7 million in Q4 2024 and bottomed at -$3.9 million in Q3 2024.
• The 5-year median for Capital Expenditures is $898918.0 (2022), against an average of $1.9 million.
• Biggest YoY gain for Capital Expenditures was 177167.65% in 2024; the steepest drop was 665.9% in 2024.
• Year by year, Capital Expenditures stood at $400000.0 in 2022, then jumped by 185.3% to $1.1 million in 2023, then surged by 746.84% to $9.7 million in 2024, then tumbled by 75.18% to $2.4 million in 2025, then jumped by 155.9% to $6.1 million in 2026.
• Per Business Quant, the three latest ASPI Capital Expenditures figures stand at $6.1 million (Q1 2026), $2.4 million (Q4 2025), and $7.4 million (Q3 2025).